We have shown that hypermethylation of RAR-2β,  GSTP1, PDLIM4, and FLNC facilitates the diagnosis of prostate cancer with a sensitivity and specificity of 87.3% and 87.1%, respectively [24, 82, 117]. This evidence concerns the gene GSTP1 and prostate cancer.